BACKGROUND: Renal dysfunction is recognized as an important risk factor for
thromboembolic (TE) events in patients with atrial fibrillation (AF) under medical treatment …

Introduction Whether successful catheter ablation for atrial fibrillation (AF) reduces risk of
cerebrovascular events (CVEs) remains controversial and whether oral anticoagulation …

Introduction Atrial fibrillation (AF) is the most common arrhythmia. Hybrid convergent
ablation (HCA) is an emerging procedure for treating longstanding AF with promising …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review, focusing on 2006 to the present, was conducted through October …

Background: Although pulmonary vein (PV) antrum isolation is an established therapy for
drug-resistant paroxysmal atrial fibrillation (PAF), long-term (> 5 years) follow-up data are …

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, affecting 1% to
2% of the general population. 1 Its incidence increases dramatically with age, from less than …

Background The characteristics of patients undergoing atrial fibrillation (AF) ablation and
subsequent outcomes in community practice are not well described. Methods and Results …

Reversible Dysfunction After Persistent AF Ablation Introduction There is a paucity of data on
atrial injury following ablation of persistent atrial fibrillation (AF). This study aimed at …

Background Catheter ablation (CA) is an established therapy for atrial fibrillation (AF).
Studies regarding long‐term real‐world outcomes post‐CA have inconsistently accounted …

Background Atrial fibrillation increases thromboembolic risk. Oral anticoagulation with
antivitamin K (AVK) reduces thromboembolic event rate, but increases hemorrhagic risk …